v3.0.7
Please consider this website is continuously evolving and still under development
to harmonize automatic data extraction and integrate manual data annotation.
| Column | Value |
|---|---|
| Trial registration number | NCT04790786 |
|
Full text link
Last imported at : April 29, 2021, 10:18 a.m. Source : ClinicalTrials.gov |
|
|
First author
Last imported at : June 21, 2022, 7:30 p.m. Source : ClinicalTrials.gov |
|
|
Contact
Last imported at : June 21, 2022, 7:30 p.m. Source : ClinicalTrials.gov |
Not reported |
|
Registration date
Last imported at : May 3, 2021, 9:44 a.m. Source : ClinicalTrials.gov |
2021-03-10 |
|
Recruitment status
Last imported at : June 16, 2023, 8 a.m. Source : ClinicalTrials.gov |
Terminated |
|
Study design
Last imported at : May 3, 2021, 9:44 a.m. Source : ClinicalTrials.gov |
RCT |
|
Allocation
Last imported at : May 3, 2021, 9:44 a.m. Source : ClinicalTrials.gov |
Randomized |
|
Design
Last imported at : May 3, 2021, 9:44 a.m. Source : ClinicalTrials.gov |
Adaptive |
|
Masking
Last imported at : May 3, 2021, 9:44 a.m. Source : ClinicalTrials.gov |
Open label |
|
Center
Last imported at : March 15, 2023, 4 a.m. Source : ClinicalTrials.gov |
single-center |
|
Study aim
Last imported at : May 3, 2021, 9:44 a.m. Source : ClinicalTrials.gov |
Treatment |
|
Inclusion criteria
Last imported at : May 3, 2021, 9:44 a.m. Source : ClinicalTrials.gov |
inclusion criteria: - covid-19 positive patients - eligible for mab under fda eua |
|
Exclusion criteria
Last imported at : May 3, 2021, 9:44 a.m. Source : ClinicalTrials.gov |
- death is deemed to be imminent or inevitable - previous participation in this remap within the last 90 days |
|
Number of arms
Last imported at : April 23, 2022, 1:30 a.m. Source : ClinicalTrials.gov |
5 |
|
Funding
Last imported at : April 23, 2022, 1:30 a.m. Source : ClinicalTrials.gov |
Erin McCreary |
|
Inclusion age min
Last imported at : May 3, 2021, 9:44 a.m. Source : ClinicalTrials.gov |
12 |
|
Inclusion age max
Last imported at : May 3, 2021, 9:44 a.m. Source : ClinicalTrials.gov |
120 |
|
Countries
Last imported at : May 3, 2021, 9:44 a.m. Source : ClinicalTrials.gov |
United States |
|
Type of patients
Last imported at : May 3, 2021, 9:44 a.m. Source : ClinicalTrials.gov |
No restriction on type of patients |
|
Severity scale
Last imported at : May 3, 2021, 9:44 a.m. Source : ClinicalTrials.gov |
0: No restriction on type of patients |
|
Total sample size
Last imported at : June 16, 2023, 8 a.m. Source : ClinicalTrials.gov |
4571 |
|
primary outcome
Last imported at : June 16, 2023, 8 a.m. Source : ClinicalTrials.gov |
Hospital-free Days |
|
Notes
Last imported at : May 3, 2021, 9:44 a.m. Source : ClinicalTrials.gov |
None |
|
Phase
Last imported at : May 19, 2022, 8:39 a.m. Source : ClinicalTrials.gov |
Phase 4 |
|
Arms
Last imported at : April 23, 2022, 1:30 a.m. Source : ClinicalTrials.gov |
[{"arm_notes": "nan", "treatment_id": 1861, "treatment_name": "Bebtelovimab", "treatment_type": "Monoclonal antibodies", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": 179, "treatment_name": "Bamlanivimab", "treatment_type": "Monoclonal antibodies", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": 1426, "treatment_name": "Bamlanivimab+etesevimab", "treatment_type": "Monoclonal antibodies", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": 1864, "treatment_name": "Casirivimab+imdevimab", "treatment_type": "Monoclonal antibodies", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": 1859, "treatment_name": "Sotrovimab", "treatment_type": "Monoclonal antibodies", "pharmacological_treatment": "Pharmacological treatment"}] |